Developed by Northwestern Engineering’s Igor Efimov and George Washington University’s Luyao Lu, the implantable device uses ...
The new ACC and AHA criteria for cardiac devices emphasize more risk stratification, reflecting advances in the field in ...
Frederic E. Van Heuverswyn, M.D; Liesbeth Timmers, M.D; Roland X. Stroobandt, M.D., Ph.D; S. Serge Barold, M.D Devices have to be exported in compliance with local ...
The subcutaneous formulation of Opdivo provides a convenient alternative to intravenous administration for patients with solid tumors, maintaining efficacy and safety. The CHECKMATE-67T trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results